Remove tag middle-east
article thumbnail

Cannabinoids receptors: popular preclinical target but banned in 137 countries

Pharmaceutical Technology

Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. In Asia, Africa and the Middle East, cannabinoid-based drugs are mostly illegal and continue to present a major regulatory obstacle.

article thumbnail

The pharmaceutical industry found it easier to fill artificial intelligence vacancies in Q3 2022

Pharmaceutical Technology

The next most difficult place to fill these roles was found to be North America, while the Middle East and Africa was in third place. On a regional level, these roles were hardest to fill in Europe, with related jobs that were taken offline in Q3 2022 having been online for an average of 42.8

84
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The pharma industry found it harder to fill digitalization vacancies in Q1 2022

Pharmaceutical Technology

At the opposite end of the scale, jobs were filled fastest in the Middle East and Africa, with adverts taken offline after 12 days on average. The next most difficult place to fill these roles was found to be Asia-Pacific, while North America was in third place.

59
article thumbnail

Global (68M) cardiomyopathies market projected to grow to $9.63bn by 2031

Pharmaceutical Technology

The Cardiomyopathies: 68-Market Analysis and Sales Forecast report covers a total of 68 markets across Africa, Asia-Pacific (APAC), Europe, Latin America (LATAM), the Middle East and North America. The second highest contributing market is APAC, generating 33.2% of global cardiomyopathies sales in 2021 and 31.2%

52
article thumbnail

CEPI provides $30m to advance novel coronavirus vaccine

European Pharmaceutical Review

“We are delighted to be working with CEPI to further this nanoparticle technology with the goal of producing efficacious, low-cost, infrastructure-independent vaccine that will be accessible to low- and middle-income countries.” . How the novel coronavirus vaccine works. The innovative protein ?“glue”

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

We are now in a 20-yearlong economic depression for the working and middle class as a result of health care prices inflating, prices not cost. Dave (HR): Yeah, I mean really everything we’re doing you know is about overturning the devastating effects of the status quo health plans. So that individuals can realize their full potential.